FREE Account Opening + No Clearing Fees
Loading...

Marksans Pharma Buyback Latest News Today

Marksans Pharma Buyback Detail
Buyback Record Date
Buyback Open Date July 15, 2022
Buyback Closing Date January 14, 2023
Issue Size (Amount) ₹60.00 Crores
Buyback Price ₹60 per Share
  1. This Pharma Stock Has Slumped 11% In 30 Days, But Analysts Forecast Over 110% Rally Ahead

    March 18, 2024 11:33:00 AM

    Shares of Marksans Pharma have been on a downtrend since the start of the year. In the last 30 days, the stock has called around 11%, but analysts at Ventura are optimistic about the company�s ...

    Published by : Benzinga India on MSN
  2. Marksans Pharma Ltd

    April 16, 2024 3:30:00 AM

    We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

    Published by : Morningstar
  3. Marksans Pharma Ltd (MARKSANS) Share Price

    April 16, 2024 3:30:00 AM

    Marksans Pharma Ltd share price was up by 13.38% from the previous closing price of ?155.85. Who are peers of Marksans Pharma Ltd? The peers of Marksans Pharma Ltd are Sun Pharmaceuticals ...

    Published by : Business Today
  4. 5 Stocks With Strong Buyback Programs

    March 27, 2024 12:29:00 AM

    What Is A Stock Buyback? A stock buyback, also called a share repurchase, occurs when a company returns its shares from the marketplace. This action reduces the number of outstanding shares and ...

    Published by : Forbes
  5. Marksans Pharma

    May 31, 2023 12:31:00 AM

    Arihant Capital is bullish on Marksans Pharma has recommended buy rating on the stock with a target price of Rs 80 in its research report dated August 19, 2022. The share touched a 52-week high of ...

    Published by : moneycontrol.com
  6. Marksans Pharma Ltd (MARK)

    March 20, 2024 3:30:00 AM

    Three Inside Up 15 69 Mar 20, 2024 01:30AM ...

    Published by : Investing
  7. MARKSANS PHARMA

    November 7, 2017 8:57:00 PM

    Marksans Pharma has received approval from the US health regulator for loratadine liquid filled capsules, used for treatment of allergies, in the American market. The company has been granted the ...

    Published by : health.economictimes.indiatimes
  8. Marksans Pharma Ltd.

    April 16, 2024 3:30:00 AM

    The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

    Published by : Wall Street Journal

Read Marksans Pharma Buyback current news. Find Marksans Pharma Buyback subscription news, Buyback analysis, broker reviews, allotment news, and listing date. Get the Marksans Pharma Ltd Buyback grey market premium and Marksans Pharma Buyback expected listing price.